ClinicalTrials.gg
RecruitingNCT06668519Updated Mar 25, 2026

Magnetoencephalography in Children

An observational study in Epilepsy, Intracranial Tumors and Cerebrovascular Disease, sponsored by Children's Hospital of Fudan University. Recruiting at 1 site in China. Open to participants aged 1 Month to 18 Years. Per ClinicalTrials.gov, last updated 2026-03-25.

Sponsored by Children's Hospital of Fudan University · Observational

From the registry’s dates

  • Started Sep 2024; still recruiting 2 years 1 month later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,500
Ages
1 Month to 18 Years
Sex
All
01

Study summary

This study is a single-center observational clinical study, which evaluates the diagnostic value of magnetoencephalography (MEG) in the diagnosis of neurodevelopmental diseases in children, such as the localization of epileptic foci and brain functional areas, intracranial tumors, cerebrovascular diseases, autism, mental retardation, and neuropsychiatric disorders.

Read the detailed description

The purpose of this study is to observe the application of magnetoencephalography (MEG) in pediatric neurodevelopmental disorders

02

Conditions studied

  • Epilepsy
  • Intracranial Tumors
  • Cerebrovascular Disease
  • Autism
  • ADHD - Attention Deficit Disorder With Hyperactivity
  • Neuropsychiatric Disorders
  • Tic Disorder, Childhood
  • Mental Retardation
  • Developmental Disabilities

Keywords

  • neurodevelopmental diseases
  • magnetoencephalography
  • pediatric
03

In context

Epilepsy

1,848 studies on the registry are indexed under Epilepsy; 422 are open to participants now.

This study's planned enrollment of 1,500 is above the median of 112 across 540 observational studies indexed under Epilepsy.

Browse Epilepsy studies →

Lead sponsor

Children's Hospital of Fudan University is the lead sponsor of 268 studies on the registry; 95 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Month to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Children aged 1 month to 18 years old

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. aged 1 month-18 years old (date of investigate minus date of birth)
  2. epilepsy
  3. intracranial tumors
  4. cerebrovascular diseases
  5. autism
  6. mental retardation
  7. ADHD
  8. tic disorder
  9. neuropsychiatric disorders

Exclusion criteria

Exclusion Criteria:

1.Unable to cooperate with the exam of MEG

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,500 participants (estimated)
Target follow-up
3 Years
Patient registry
Yes

Groups and cohorts

  • children with neurodevelopmental diseases

    Other: Magnetoencephalography

  • healthy children

    Other: Magnetoencephalography

Interventions

  • OtherMagnetoencephalography

    Magnetoencephalography

06

What researchers measure

Primary outcomes

  1. Difference in magnetoencephalography (MEG) signal between children with neurodevelopmental diseases and healthy children

    Acquisition of magnetoencephalography (MEG) signals based on Inclusion Criteria

    Time frame: 3 years

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06668519
Responsible party
Sponsor
First posted
Oct 31, 2024
Start date
Sep 25, 2024
Primary completion
Dec 30, 2027 (estimated)
Completion
Dec 30, 2027 (estimated)
Last update
Mar 25, 2026

Study contacts

Yuanfeng Zhou
Contact
yuanfengzhou@fudan.edu.cn
18916152087

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion